BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10572111)

  • 1. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants.
    Cavet J; Middleton PG; Segall M; Noreen H; Davies SM; Dickinson AM
    Blood; 1999 Dec; 94(11):3941-6. PubMed ID: 10572111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants.
    Middleton PG; Taylor PR; Jackson G; Proctor SJ; Dickinson AM
    Blood; 1998 Nov; 92(10):3943-8. PubMed ID: 9808588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Cavet J; Dickinson AM; Norden J; Taylor PR; Jackson GH; Middleton PG
    Blood; 2001 Sep; 98(5):1594-600. PubMed ID: 11520812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis.
    Kögler G; Middleton PG; Wilke M; Rocha V; Esendam B; Enczmann J; Wernet P; Gluckman E; Querol S; Lecchi L; Goulmy E; Dickinson AM
    Transplantation; 2002 Oct; 74(8):1167-75. PubMed ID: 12438965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation.
    Middleton PG; Cullup H; Dickinson AM; Norden J; Jackson GH; Taylor PR; Cavet J
    Bone Marrow Transplant; 2002 Aug; 30(4):223-8. PubMed ID: 12203138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation.
    Nordlander A; Uzunel M; Mattsson J; Remberger M
    Br J Haematol; 2002 Dec; 119(4):1133-6. PubMed ID: 12472598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
    Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
    Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantation.
    Bettens F; Passweg J; Gratwohl A; Chalandon Y; Helg C; Chapuis B; Schanz U; Libura J; Roosnek E; Tiercy JM
    Transplantation; 2006 May; 81(9):1261-7. PubMed ID: 16699452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
    MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
    Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow.
    Neudorf SM; Rybka W; Ball E; Blatt J; Bloom E; Corey S; deMagalhaes-Silverman M; Koehler M; Lister J; Mierski J; Mirro J; Pincus S; Wilson J; Wollman M; Donnenberg AD
    J Hematother; 1997 Aug; 6(4):351-9. PubMed ID: 9377073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.
    Granero Farias M; Andrade Dos Santos C; de Mello Vicente B; Habigzang M; de Oliveira da Silva P; Emerim Lemos N; Dieter C; Paz A; Esteves Daudt L
    Hum Immunol; 2020 Jan; 81(1):18-25. PubMed ID: 31889553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation.
    Rocha V; Franco RF; Porcher R; Bittencourt H; Silva WA; Latouche A; Devergie A; Esperou H; Ribaud P; Socie G; Zago MA; Gluckman E
    Blood; 2002 Dec; 100(12):3908-18. PubMed ID: 12393699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience.
    Goussetis E; Varela I; Peristeri I; Kitra V; Spanou K; Moraloglou O; Paisiou A; Karatasaki S; Soldatou A; Constantinidou N; Graphakos S
    Cell Mol Immunol; 2011 May; 8(3):276-80. PubMed ID: 21358669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants.
    Cullup H; Dickinson AM; Jackson GH; Taylor PR; Cavet J; Middleton PG
    Br J Haematol; 2001 Jun; 113(3):807-13. PubMed ID: 11380474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of bone marrow transplantation from HLA-identical sibling donor in children with hematological malignancies using methotrexate alone as prophylaxis for graft-versus-host disease.
    Watanabe N; Matsumoto K; Yoshimi A; Horibe K; Matsuyama T; Kojima S; Kato K
    Int J Hematol; 2008 Dec; 88(5):575-582. PubMed ID: 19043808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.